Ex-Stryker CEO to head disinfectant firm

Eight months after his abrupt resignation from Stryker ($SYK), Stephen MacMillan has landed a job as the CEO of sBioMed, an Orem, UT, maker of clinical anti-infection agents. In an interview with Mass Device, MacMillan described his very public exit from Stryker as "unfair, unfortunate and personally challenging," but said he's enthusiastic to start at sBioMed, which is scaling up commercialization of its Steriplex SD solution. Release | Interview